Liarozole, an antitumor drug, modulates cytokeratin expression in the dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid
Dr G. Smets, R. van Ginckel, G. Daneels, M. Moeremans, J. van Wauwe, M.-C. Coene, F. C. S. Ramaekers, J. A. Schalken, M. Borgers, R. de CosterVolume:
27
Year:
1995
Language:
english
Pages:
12
DOI:
10.1002/pros.2990270303
File:
PDF, 1017 KB
english, 1995